---
title: "Reviews — glucosamine and chondroitin high strength - Flapen"
canonical_url: "https://flapen.com/research/uk/health-personal-care/glucosamine-and-chondroitin-high-strength/reviews"
last_updated: "2026-07-31T12:48:49.020Z"
locale: en
meta:
  description: "Niche score 54/100 · £873K/yr market · 522K searches/yr · £12.09 avg price. Soft demand (-14.1% this quarter) keeps it on the watch list. Data updated Jul 2026."
  "og:description": "Niche score 54/100 · £873K/yr market · 522K searches/yr · £12.09 avg price. Soft demand (-14.1% this quarter) keeps it on the watch list. Data updated Jul 2026."
  "og:title": "Reviews — glucosamine and chondroitin high strength - Flapen"
---

# **glucosamine and chondroitin high strength**

**Worth a look**

Shows low returns (0.1%), but soft demand (-14.1% this quarter) keeps it on the watch list.

Market size 75Growth 18Conversion 96Competition 28Returns 100Price range 46Avg price 51Brand share 52Review moat 40Quality gap 37

**Returns**

**Incredible****0.1%**

return rate — above 5% kills the launch gate

**Conversion**

**Incredible****13.8%**

search→purchase rate — share of searches ending in a sale

**Market size**

**Great****£873K**

£873K/yr · 522K searches

**Brand share**

**Good****74%**

top-5 brand share — brands hold most of the demand

**Avg price**

**Good****£12.09**

avg listing price — sweet spot $15–$100

**Price range**

**Okay****£5.01–£23.65**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Review moat**

**Okay****2,497.39**

avg incumbent reviews — the moat a new listing must climb

**Quality gap**

**Okay****4.5★**

avg incumbent rating — lower means beatable quality

**Competition**

**Okay****68%**

top-5 click share — leaders hold, buyers still browse

**Growth**

**Bad****-14.1%**

90-day search growth — must beat 0% to launch